Vivante Health Announces Collaboration with Janssen for Predictive Disease Modeling

Houston, TX, March 17, 2020 – Vivante Health, the leader in digital medicine for gut health and disease, proudly announced a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop digital predictive biomarkers for chronic diseases. The agreement was facilitated by Johnson & Johnson Innovation LLC. The…

Read more

Vivante Health Closes $5.8 Million Series A1 Investments

Houston, TX, January 20, 2020 – Vivante Health, the leader in digital medicine for gut health and disease, announced completion of its Series A1 investments this week after closing with healthcare investor Lifeforce Capital and tech-focused European investment firm, Big Pi Ventures, based in Athens. NFP Ventures, FCA Venture Partners, and Longmont Capital also participated…

Read more

Reta Trust, Vivante Health Team up for Digestive Health

Digital gut health program open to 30 thousand eligible members Houston, TX, November 4, 2019 – Vivante Health, the digestive health experts and creators of the GIThrive all-in-one digital program for gut health and disease, is pleased to announce its partnership with Reta Trust, a non-profit ERISA trust providing affordable healthcare options to Catholic organizations…

Read more
Vivante Health and Rock Health Logo

Our Latest Investor: Rock Health

Houston, TX, July 23, 2019 – On July 15, San Francisco-based Rock Health, the first venture fund devoted to digital healthcare, officially announced its latest investment with a piece aptly titled, “Better health, gut first: Our investment in Vivante Health.”       “While employers increasingly offer programs for other chronic conditions, digestive health remains…

Read more

Vivante Health Proudly Welcomes Katharine Moore as Chief Business Development Officer

Houston, TX, March 4, 2019 – Vivante Health, the digestive health experts and creators of GIThrive, the first-ever comprehensive digital program for gut health and disease, announced today the hiring of Katharine Moore as Chief Business Development Officer. In this executive-level role, Ms. Moore will lead strategic partnerships across the healthcare ecosystem and support product…

Read more